During the past decade, University of Wisconsin Clinical Science Center conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 6 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 5 clinical trials were completed. i.e. 35.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Wisconsin Clinical Science Center" #1 sponsor was "Pfizer" with 6 trials, followed by "Gilead Sciences" with 3 trials sponsored, "Adaptimmune" with 1 trials sponsored, "Alliance Foundation Trials, LLC." with 1 trials sponsored and "Aravive, Inc." with 1 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Wisconsin Clinical Science Center" #1 collaborator was "Astellas Pharma Inc" with 3 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "University of Wisconsin Clinical Science Center" are "Advanced Solid Tumor" (2 trials), "Breast Cancer" (2 trials), "Non-small Cell Lung Cancer" (2 trials), "Solid Tumors" (2 trials) and "Acute Myelogenous Leukemia" (1 trials). Many other conditions were trialed in "University of Wisconsin Clinical Science Center" in a lesser frequency.

Most popular intervention types in "University of Wisconsin Clinical Science Center" are "Drug" (25 trials), "Biological" (1 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cetuximab" (2 trials), "Encorafenib" (2 trials), "Irinotecan" (2 trials), "Nivolumab" (2 trials) and "Zimberelimab" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Wisconsin Clinical Science Center" are 23 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Wisconsin Clinical Science Center". undefined are not yet recruiting, 7 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in University of Wisconsin Clinical Science Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of Wisconsin Clinical Science Center, 7 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".